About Us
How can we help you? Feel free to reach out to us with any MedRod product inquiries or collaboration opportunities!
Sustained Release Drug Delivery
PreclinApps Ltd was founded in 2014 by co-founders. Our mission is to develop novel sustained release systems that are scientifically better, cost-efficient, more ethical for animals and have better compliance for patients. To achieve this goal, we have sustained release technology platforms that enable stable release of small to macromolecules from days to several years.
The company was founded by experienced professionals in drug development with long history from large, midsize pharma and CRO environment. Our mission is to develop novel sustained release drug delivery systems that are scientifically better, cost-efficient, more ethical for animals and have better compliance for patients. To achieve this goal, we have sustained release drug delivery platforms that enable stable release of small to macromolecules from days to several years in preclinical studies.
Preclinapps has research facilities at the Smart Chemistry Park (SCP) in Raisio, Southwest Finland. SCP is an innovation platform for bio- and circular economies which core competence lies in different fields of chemistry.
Preclinapps is proud to operate cutting-edge research facilities at the Smart Chemistry Park (SCP) in Raisio, located in the heart of Southwest Finland. SCP serves as an innovation hub designed to accelerate advancements in bioeconomy and circular economy solutions. Specializing in various fields of chemistry and biomedicine, SCP fosters a collaborative environment that enables pioneering research and development.
With a focus on sustainable and innovative practices, SCP brings together experts in biochemistry and biomedical sciences, providing Preclinapps with access to state-of-the-art resources and a thriving scientific community. This unique setting not only enhances our research capabilities but also aligns with our commitment to developing impactful solutions for the future of health and environmental sustainability.
The Team
Management Team and CO-Founders
Jukka Rissanen
PhD in anatomy and cell biology
Over 20 years of experience in preclinical drug development and management roles in both scientific and operational functions.
Harri Jukarainen
MSc in chemical engineering
25 years of experience in developing novel drug delivery polymers and combination products for healthcare use, various R&D and management roles from big pharma to start-up companies.
Saku Ruohonen
PhD, Toxicologist, Adjunct Professor of Pharmacology
Over 20 years of experience in preclinical disease models and drug development in academic research and industry.
Read more about our services
Learn more about what we offer by exploring our services in detail.